Sublingual Y-2(Adaravone And Borneol) Tablet For Acute Ischemic And Hemorrhagic Patients-the SALVAGE Trial
Phase of Trial: Phase I
Latest Information Update: 16 Nov 2018
At a glance
- Drugs Y-2 (Primary)
- Indications Intracranial haemorrhages; Stroke
- Focus Adverse reactions
- Acronyms SALVAGE
- Sponsors YenePharma
- 01 Nov 2018 Planned End Date changed from 1 Oct 2018 to 1 Mar 2019.
- 01 Nov 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Jan 2019.
- 01 Nov 2018 Status changed from not yet recruiting to recruiting.